DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Galena Biopharma, Inc. (NASDAQ: GALE)

1.57 -0.05 (-3.09%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GALE $1.57 -3.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.60
Previous Close $1.62
Daily Range $1.57 - $1.62
52-Week Range $1.51 - $7.77
Market Cap $190.7M
P/E Ratio -2.13
Dividend (Yield) $0.00 (0.0%)
Volume 1,918,084
Average Daily Volume 1,473,425
Current FY EPS -$0.36





Galena Biopharma, Inc. (GALE) Description

Galena Biopharma Inc is a biotechnology company focused on discovering developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics. Website:

News & Commentary

This is Incredibly Good News for Breast Cancer Survivors

A recently released study from Canada shines light on the advancements made in treating breast cancer over the past two decades.

Adam Feuerstein's 2014 Biotech Stock Report Card (No Grading on a Curve)

Nominees for Absolute Worst Bio-Technology CEOs of 2014 Are ...

Galena: I Am Bullish, However, Nobody Has Paid Me For My Stance

Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data At The 56th A

Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data At The 56th American Society of

Why Galena Biopharma Inc. Stock Sank 13% in November

Galena Biopharma stock sinks below $2 per share following a weaker-than-expected earnings report and an unfavorable financing deal.

Health Care Sector Update for 12/02/2014: GWPH, ACRX, GALE

Galena, Shunned by Wall Street, Forced to Seek Pricey Vulture Financing

Health Care Sector Update for 11/21/2014: GALE,NEPT,AMDA

UPDATE: MLV & Co Reiterates On Galena Biopharma As External Risks Have Subsided

See More GALE News...

GALE's Top Competitors

GALE $1.57 (-3.09%)
Current stock: GALE
AMGN $170.17 (1.00%)
Current stock: AMGN
GILD $108.45 (2.76%)
Current stock: GILD
BIIB $360.67 (1.97%)
Current stock: BIIB